SSG Capital Advisors acted as the investment banker to Unilife in the sale of substantially all of its assets to UNL Holdings, an affiliate of OrbiMed Advisors and Amgen.
Natera, a provider of non-invasive genetic testing and analysis of circulating cell-free DNA, entered into a $100 million credit agreement with OrbiMed Royalty Opportunities II as the lender.
Dutch pharmaceutical firm Pharming Group replaced its $100 million bridge finance with a $100 million permanent facility agreement. OrbiMed provided both financings.
Xtant Medical Holdings entered into an amendment to its credit facility with OrbiMed Advisors for up to $15 million in financing to payoff SVB and for working capital.
Unilife has secured $7 million debtor-in-possession financing from OrbiMed Advisors as part of its restructuring process via a voluntary petition under Chapter 11 of the U.S. Bankruptcy Code.
Iroko Pharmaceuticals announced it entered into a $75 million facility with an OrbiMed Advisors affiliate to support operations and its ZORVOLEX™ launch. MTS Securities acted as financial advisor.